These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 32509400)
1. MLL5α activates AR/NDRG1 signaling to suppress prostate cancer progression. Quan Y; Cui Y; Wahafu W; Liu Y; Ping H; Zhang X Am J Cancer Res; 2020; 10(5):1608-1629. PubMed ID: 32509400 [TBL] [Abstract][Full Text] [Related]
2. The role of N-cadherin/c-Jun/NDRG1 axis in the progression of prostate cancer. Quan Y; Zhang X; Butler W; Du Z; Wang M; Liu Y; Ping H Int J Biol Sci; 2021; 17(13):3288-3304. PubMed ID: 34512147 [TBL] [Abstract][Full Text] [Related]
3. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells. Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225 [TBL] [Abstract][Full Text] [Related]
4. Androgen receptors in hormone-dependent and castration-resistant prostate cancer. Shafi AA; Yen AE; Weigel NL Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of N-myc downstream regulated gene 1 caused by the methylation of CpG islands of NDRG1 promoter promotes proliferation and invasion of prostate cancer cells. Li Y; Pan P; Qiao P; Liu R Int J Oncol; 2015 Sep; 47(3):1001-8. PubMed ID: 26202882 [TBL] [Abstract][Full Text] [Related]
6. Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer. Savoy RM; Chen L; Siddiqui S; Melgoza FU; Durbin-Johnson B; Drake C; Jathal MK; Bose S; Steele TM; Mooso BA; D'Abronzo LS; Fry WH; Carraway KL; Mudryj M; Ghosh PM Endocr Relat Cancer; 2015 Jun; 22(3):369-86. PubMed ID: 25759396 [TBL] [Abstract][Full Text] [Related]
7. Castration induces up-regulation of intratumoral androgen biosynthesis and androgen receptor expression in an orthotopic VCaP human prostate cancer xenograft model. Knuuttila M; Yatkin E; Kallio J; Savolainen S; Laajala TD; Aittokallio T; Oksala R; Häkkinen M; Keski-Rahkonen P; Auriola S; Poutanen M; Mäkelä S Am J Pathol; 2014 Aug; 184(8):2163-73. PubMed ID: 24949550 [TBL] [Abstract][Full Text] [Related]
8. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer. Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197 [TBL] [Abstract][Full Text] [Related]
9. A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer. Gu P; Chen X; Xie R; Xie W; Huang L; Dong W; Han J; Liu X; Shen J; Huang J; Lin T Mol Cancer; 2019 Jun; 18(1):109. PubMed ID: 31221168 [TBL] [Abstract][Full Text] [Related]
10. Crosstalk Between AR and Wnt Signaling Promotes Castration-Resistant Prostate Cancer Growth. Luo J; Wang D; Wan X; Xu Y; Lu Y; Kong Z; Li D; Gu W; Wang C; Li Y; Ji C; Gu S; Xu Y Onco Targets Ther; 2020; 13():9257-9267. PubMed ID: 32982312 [TBL] [Abstract][Full Text] [Related]
11. Targeting androgen receptor versus targeting androgens to suppress castration resistant prostate cancer. Guo C; Yeh S; Niu Y; Li G; Zheng J; Li L; Chang C Cancer Lett; 2017 Jul; 397():133-143. PubMed ID: 28323036 [TBL] [Abstract][Full Text] [Related]
12. Investigation of lncRNA H19 in prostate cancer cells and secreted exosomes upon androgen stimulation or androgen receptor blockage. Ozgur E; Gezer U Bratisl Lek Listy; 2020; 121(5):362-365. PubMed ID: 32356434 [TBL] [Abstract][Full Text] [Related]
13. ASC-J9 Lin W; Luo J; Sun Y; Lin C; Li G; Niu Y; Chang C Cancer Lett; 2018 Jul; 425():21-30. PubMed ID: 29425687 [TBL] [Abstract][Full Text] [Related]
14. A hnRNP K⁻AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer. Capaia M; Granata I; Guarracino M; Petretto A; Inglese E; Cattrini C; Ferrari N; Boccardo F; Barboro P Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966326 [TBL] [Abstract][Full Text] [Related]
15. Foxa2 activates the transcription of androgen receptor target genes in castrate resistant prostatic tumors. Connelly ZM; Yang S; Chen F; Yeh Y; Khater N; Jin R; Matusik R; Yu X Am J Clin Exp Urol; 2018; 6(5):172-181. PubMed ID: 30510969 [TBL] [Abstract][Full Text] [Related]
16. Potential impact of combined inhibition of 3α-oxidoreductases and 5α-reductases on prostate cancer. Fiandalo MV; Gewirth DT; Mohler JL Asian J Urol; 2019 Jan; 6(1):50-56. PubMed ID: 30775248 [TBL] [Abstract][Full Text] [Related]
17. Preclinical Study Using ABT263 to Increase Enzalutamide Sensitivity to Suppress Prostate Cancer Progression Via Targeting BCL2/ROS/USP26 Axis Through Altering ARv7 Protein Degradation. Xu H; Sun Y; Huang CP; You B; Ye D; Chang C Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235588 [TBL] [Abstract][Full Text] [Related]
18. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression. Shiota M; Takeuchi A; Song Y; Yokomizo A; Kashiwagi E; Uchiumi T; Kuroiwa K; Tatsugami K; Fujimoto N; Oda Y; Naito S Endocr Relat Cancer; 2011 Aug; 18(4):505-17. PubMed ID: 21652770 [TBL] [Abstract][Full Text] [Related]
19. Citrus Flavone Tangeretin Inhibits CRPC Cell Proliferation by Regulating Cx26, AKT, and AR Signaling. Zhang N; Wu W; Huang Y; An L; He Z; Chang Z; He Z; Lai Y Evid Based Complement Alternat Med; 2022; 2022():6422500. PubMed ID: 35111229 [TBL] [Abstract][Full Text] [Related]
20. TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer. Siu MK; Chen WY; Tsai HY; Chen HY; Yin JJ; Chen CL; Tsai YC; Liu YN Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):172-178. PubMed ID: 28220803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]